相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents Results From a Registry of 18,334 Patients
Tomohisa Tada et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
Roxana Mehran et al.
LANCET (2013)
Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study
Mette Charlot et al.
EUROPEAN HEART JOURNAL (2012)
Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials
Salvatore Cassese et al.
EUROPEAN HEART JOURNAL (2012)
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
In-Stent Neoatherosclerosis A Final Common Pathway of Late Stent Failure
Seung-Jung Park et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Clopidogrel tapering as a strategy to attenuate platelet rebound phenomenon in patients with bare-metal stents
Idit Yedidya et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)
Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation
Philipp Diehl et al.
CLINICAL RESEARCH IN CARDIOLOGY (2011)
Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study
Nalyaka Sambu et al.
HEART (2011)
Will We Ever Know the Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation?
Adnan Kastrati et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Abrupt Cessation of One-Year Clopidogrel Treatment Is Not Associated With Thrombotic Events
Nina Djukanovic et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Beware of being caught on the rebound
M. Lordkipanidze et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Clopidogrel discontinuation and platelet reactivity following coronary stenting
D. Mylotte et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Absence of rebound platelet hyperreactivity following cessation of prasugrel
Joseph A. Jakubowski et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Clopidogrel withdrawal: Is there a rebound phenomenon?
Nalyaka Sambu et al.
THROMBOSIS AND HAEMOSTASIS (2011)
The Platelet Activity After Clopidogrel Termination (PACT) Study
Andrew L. Frelinger et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Adverse Events After Stopping Clopidogrel in Post-Acute Coronary Syndrome Patients Insights From a Large Integrated Healthcare Delivery System
P. Michael Ho et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Patients With Previous Definite Stent Thrombosis Have a Reduced Antiplatelet Effect of Aspirin and a Larger Fraction of Immature Platelets
Morten Wurtz et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
A Double-Blind, Randomized Study on Prevention and Existence of a Rebound Phenomenon of Platelets After Cessation of Clopidogrel Treatment
Dirk Sibbing et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
TCT-471: Is There a Platelet Rebound Effect to Stopping Clopidogrel ?
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
Stefanie Schulz et al.
EUROPEAN HEART JOURNAL (2009)
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study
Joanna J. Wykrzykowska et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Benefit of Clopidogrel for acute coronary syndrome and percutaneous coronary interventions in doubt due to rebound adverse events
David K. Cundiff
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome
P. Michael Ho et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Outcomes associated with drug-eluting and bare-metal stents:: a collaborative network meta-analysis
Christoph Stettler et al.
LANCET (2007)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
Adnan Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial
V. L. Serebruany et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents - An observational study of drug-eluting versus bare-metal stents
Matthias Pfisterer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease
DJ Angiolillo et al.
DIABETES (2006)
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents
PK Kuchulakanti et al.
CIRCULATION (2006)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Coronary syndromes following aspirin withdrawal - A special risk for late stent thrombosis
E Ferrari et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Acute stent thrombosis after early withdrawal of platelet glycoprotein IIb/IIIa antagonists:: Potential rebound prothrombotic effect?
DJ Angiolillo et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2003)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
分享论文
